Literature DB >> 17911872

Computerized management of chronic anticoagulation: three years of experience.

Beatriz H Rocha1, Laura H Langford, Steven Towner.   

Abstract

Chronically anticoagulated patients taking the drug Warfarin require time intensive management and followup processes to avoid complications. The "Chronic Anticoagulation Clinic" (CAC) protocol is a set of production rules that help manage, treat, and follow-up such patients. The CAC protocol has been in regular use at Intermountain Healthcare (Salt Lake City, UT, USA) for over three years. The results demonstrate an improvement on the number of patients with anticoagulation levels within the desired target range. The protocol alerts have a high acceptance rate (83.4%) and were able to help patients remember to collect their next coagulation test. The CAC protocol results show that production rules can improve the management of chronically anticoagulated patients. Additional studies are required to verify if this experience can be transferred to other institutions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911872

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  4 in total

1.  Management of warfarin in children with heart disease.

Authors:  William T Mahle; Scott A Simpson; Paulette Fye; Michael E McConnell
Journal:  Pediatr Cardiol       Date:  2011-04-17       Impact factor: 1.655

2.  Computerization of Mental Health Integration complexity scores at Intermountain Healthcare.

Authors:  Thomas A Oniki; Drayton Rodrigues; Noman Rahman; Saritha Patur; Pascal Briot; David P Taylor; Adam B Wilcox; Brenda Reiss-Brennan; Wayne H Cannon
Journal:  AMIA Annu Symp Proc       Date:  2014-11-14

3.  Design of a decision support system to help clinicians manage glycemia in patients with type 2 diabetes mellitus.

Authors:  David Rodbard; Robert A Vigersky
Journal:  J Diabetes Sci Technol       Date:  2011-03-01

4.  Atrial Fibrillation Patients Treated With Long-Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long-Term Warfarin for Other Indications.

Authors:  T Jared Bunch; Heidi T May; Tami L Bair; Brian G Crandall; Michael J Cutler; John D Day; Victoria Jacobs; Charles Mallender; Jeffrey S Osborn; Scott M Stevens; J Peter Weiss; Scott C Woller
Journal:  J Am Heart Assoc       Date:  2016-07-11       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.